Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Cantel Medical (CMN) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 3,359,050
  • Shares Outstanding, K 41,700
  • Annual Sales, $ 664,760 K
  • Annual Income, $ 59,950 K
  • 36-Month Beta 1.43
  • Price/Sales 5.05
  • Price/Book 7.39
  • Price/Earnings ttm 46.01
  • Earnings Per Share ttm 1.75
  • Most Recent Earnings 0.48 on 09/29/16
  • Annual Dividend & Yield 0.12 (0.15%)
  • Most Recent Dividend 0.06 on 07/13/16
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
69.17 +17.31%
on 11/03/16
82.80 -2.00%
on 11/25/16
+11.61 (+16.70%)
since 11/02/16
3-Month
68.19 +18.99%
on 10/28/16
82.80 -2.00%
on 11/25/16
+3.98 (+5.16%)
since 09/02/16
52-Week
55.01 +47.50%
on 01/15/16
82.80 -2.00%
on 11/25/16
+14.69 (+22.11%)
since 12/02/15

Most Recent Stories

More News
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2016

CANTEL MEDICAL CORP. (NYSE:CMN) will release the results for its first quarter ended October 31, 2016 on Thursday, December 8 before the market opens, and hold a conference call to discuss the results...

Cantel Medical to Present at the Piper Jaffray 28th Annual Healthcare Conference

CANTEL MEDICAL CORP. (NYSE:CMN) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the Piper Jaffray 28th Annual Healthcare Conference at the Lotte New York Palace Hotel in...

Cantel Medical to Present at the Stifel 2016 Healthcare Conference

CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the Stifel 2016 Healthcare Conference at the Lotte New York Palace Hotel in New York. The...

Cantel Medical Announces 17% Increase In Semiannual Dividend And New Stock Symbol

CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.06 to $0.07 per outstanding share of the Company's Common Stock....

Post Earnings Coverage as Cantel Beat Expectations on Record Q4 Results

LONDON, UK / ACCESSWIRE / October 5, 2016 / Active Wall St. announces its post-earnings coverage on Cantel Medical Corp. (NYSE: CMN). The company posted its fourth quarter fiscal 2016 (Q4 FY16) and full...

Hospital Acquired Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

This report covers the market analysis for various diagnostic tests performed to detect hospital associated infections, also called as nosocomial infections. Morbidity rate of nosocomial infections is...

Cantel Medical Reports Record Results for the Fourth Quarter Ended July 31, 2016

CANTEL MEDICAL CORP. (NYSE: CMN) reported record US GAAP net income of $16,291,000, or $0.39 per diluted share, on an 18.3% increase in sales to a record $179,002,000 for the fourth quarter ended July...

Investor Calendar Invites You to the Cantel Medical Corp. Fourth Quarter and Fiscal Year 2016 Earnings Conference Call and Webcast Live on Thursday, September 29, 2016

LITTLE FALLS, NJ / ACCESSWIRE / September 28, 2016 / Cantel Medical Corp. (NYSE: CMN) will host a conference call and live webcast to discuss the results of the fourth quarter and fiscal year 2016, to...

Cantel Medical Expands its Direct Sales Operations in Canada through the Acquisition of its Endoscopy Assets from Vantage Endoscopy

CANTEL MEDICAL CORP. (NYSE: CMN), a leading global company dedicated to delivering innovative infection prevention products and services, today announced that the Company has expanded its direct sales...

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Fiscal Year Ended July 31, 2016

CANTEL MEDICAL CORP. (NYSE: CMN) will release the results for its fourth quarter and fiscal year ended July 31, 2016 on Thursday, September 29 before the market opens, and hold a conference call to discuss...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Cantel Medical Corp. is a healthcare company concentrating primarily in infection prevention and control products and diagnostic and therapeutic medical equipment. Through its United States subsidiary, MediVators, Inc., Cantel serves customers worldwide by designing, developing, manufacturing, marketing...

See More

Support & Resistance

2nd Resistance Point 83.19
1st Resistance Point 82.16
Last Price 81.14
1st Support Level 79.87
2nd Support Level 78.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.